Home Mission Technologies Pipeline Team

An AAV Research and Development Gene Therapy Company


Our Mission

To improve vision and life quality by adapting natural mechanisms using safe and single dose therapeutics.

Technologies

Human-Tropic and Antibody Evading AAV Capsids

PMID: 3263745

scIMs

Single Chain Immune Modulators

PMID: 39245940

Bedrock’s Current Gene Therapy Pipeline

Our Team

House

Jackie Bower - PhD

House

Brian Gilger - DVM, MS, DACVO

House

Matthew Hirsch - PhD

House

Chengwen Li - MD, PhD

House

Roger “Bryan” Sutton - PhD

Contact us at: info@bedrocktherapeutics.com

To the top